Evening and morning plasma levels of protein S100B in patients with obstructive sleep apnea

Neuroendocrinology Letters

Volumn 28, Issue 5, 2007, Pages 575-579

  Šonka, Karel ^a   Kelemen, Jano ^a   Kemlink, David ^a   Volná, Jana ^a   Pretl, Martin ^a   Zima, Tomáš ^a   Benákoyá, Hana ^a   Rambousek, Petr ^a   Foltán, René ^a   Donev, Filip ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Brain damage; Brain tissue; Obstructive sleep apnea; S100B protein

Indexed keywords

PROTEIN S100B;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; ELECTROIMMUNOASSAY; HEAD INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; PATHOGENESIS; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SLEEP APNEA SYNDROME; STATISTICAL SIGNIFICANCE; TIME;

EID: 38049032344     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed.: Diagnostic and coding manual. Wetchester (II): American Academy of Sleep Medicine, 2005, 1-297.
2. Bao G, Guilleminault C. Obstructive sleep apnea syndromes. In: Guilleminault C, editor. Clinical neurophysiology of sleep disorders. Handbook of clinical neurophysiology. Volume 6. Amsterdam: Elsevier 2005: 191-206.
3. Biberthaler P, Linsenmeier U, Pfeifer KJ, Kroetz M, Mussack T, Kanz KG, et al.. Serum S-100B concentration provides additional information for the indication of computed tomography in patients after minor head injury - a prospective multicenter study. Shock. 2006; 25: 446-453.
4. Biberthaler P, Mussack T, Wiedemann E, Kanz KG, Koelsch M, Gippner-Steppert C, et al. Evaluation of S-100b as a specific marker for neuronal damage due to minor head trauma. World J Surg. 2001; 25: 93-97.
5. Bottinger BW, Mobes S, Glatzer R, Bauer H, Gries A, Bartsch P, Motsch J, Martin E. Astroglial protein S100 is an early and sensitive marker of hypoxic brain damage after cardiac arrest in humans. Circulation. 2001; 103: 2694-2698.
6. Braga CW, Martinez D, Wofchuk S, Portela LV, Souza DO. S100B and NSE serum levels in obstructive sleep apnea syndrome. Sleep Med. 2006; 7: 431-435.
7. de Kruijk JR, Leffers P, Menheere PPCA, Meerhoff S, Twijnstra A. S-100B and neuron-specific enolase in serum of mild brain injury patients. Acta Neurol Scand. 2001; 103: 175-179.
8. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001; 33: 637-668.
9. Enochsson L, Carlsson-Sanz S, van der Linden J. The influence of alcohol and time on the S-100B levels of patients with minor head injury. Eur J Neurol. 2005; 12: 445-448.
10. Gerlach R, Demel G, Koenig HG, Gross U, Prehn JHM, Raabe A, et al. Active secretion of S100B from astrocytes during metabolic stress. Neurosci. 2006; 141: 1697-1701.
11. Ghanem G, Loir B, Morandini R, Sales F, Lienard D, Eggermont A, et al. On the release and half-life of S100B protein in the peripheral blood of melanoma patients. Int J Cancer. 2001; 94: 586-590.
12. Heizmann CW, Fritz G, Schafer BW. S100 proteins: structure, functions and pathology. Front Biosci. 2002; 7: D1356-D1368.
13. Hu J, Ferreira A, Van Eldik LJ: S100beta induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem. 1997; 69: 2294-2301.
14. Jordan W, Hagedohm J, Wiltfang J, Laier-Groeneveld G, Tumani H, Rodenbeck A, et al. Biochemical markers of cerebrovascular injury in sleep apnoea syndrome Eur Respir J. 2002; 20: 158-164.
15. Koppal T, Lam AG, Guo L, Van Eldik LJ: S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia. Neurochem Int. 2001; 39: 401-407.
16. Korfias S, Stranjali G, Papadimitriou A, Psachoulia C, Daskalakis G, Antsaklis A, et al. Serum S-100B protein as a biochemical marker of brain injury: A review of current concepts. Cur Med Chem. 2006; 13: 3719-3731.
17. Krahn G, Kaskel P, Sander S, Pereira J, Waizenhofer Y, Wortmann S, et al. S100B is a reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase. Anticancer Res. 2001; 21: 1311-1316.
18. Larsson A, Lipcsey M, Sjolin J, Hansson LO, Eriksson MB. Slight increase of serum S-100B during porcine endotoxemic shock may indicate blood-brain barrier damage. Anesth Analg. 2005; 101: 1465-1469.
19. Ling SH, Tang YL, Jiang F, Wiste A, Guo SS, Weng YZ, et al. Plasma S-100B protein in Chinese patients with schizophrenia: Comparison with healthy controls and effect of antipsychotics treatment. J Psy Res. 2007; 41: 36-42.
20. Missotten GS, Korse CM, van Dehn C, Linders TC, Keunen JE, Jager MJ, et al. S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening - A comparison with liver function tests. Tumour Biol. 2007; 28: 63-69.
21. Mussack T, Hauser C, Klauss V, Tato F, Rieger J, Ruppert V, et al. Serum S-100B protein levels during and after carotid artery stenting or carotid endarterectomy. J Endovasc Ther. 2006; 13: 39-46.
22. Petzold A, Jenkins R, Watt HC, Green AJE, Thompson EJ, Keir G, et al. Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease. Neurosci Lett. 2003; 336: 167-170.
23. Rosén H, Rosengren L, Herlitz J, Blomstrand C. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke. 1998; 29: 473-477.
24. Routsi C, Stamataki E, Nanas S, Psachoulia C, Stathopoulos A, Koroneos A, et al. Increased levels of serum S100B protein in critically ill patients without brain injury. Shock. 2006; 26: 20-24.
25. Schaf DV, Tort ABL, Fricke D, Schestatsky P, Portela LVC, Souza DO, et al. S100B and NSE serum levels in patients with Parkinson's disease. Parkinsonism Relat Disord. 2005; 11: 39-43.
26. Stalnacke B-M, Tegner Y, Sojka P. Playing soccer increases serum concentration of the biochemical markers of brain damage S-100B and neuron-specific enolase in elite players: a pilot study. Brain Inj. 2004; 18: 899-909.
27. Steiner J, Bernstein H-G, Bielau H, Berndt A, Brisch R, Mawrin C, et al. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci. 2007; 8: doi: 10.1186/1471-2202-8-2
28. Townend W, Dibble C, Abid K, Vail A, Sherwood R, Lecky F. Rapid elimination of protein S-100B from serum after minor head trauma, J Neurotrauma. 2006; 23: 149-155.
29. Tramontina F, Leite MC, Goncalves D, Tramontina AC, Souza DF, Frizzo JK, et al. High glutamate decreases S100B secretion by a mechanism dependent on the glutamate transporter. Neurochem Res. 2006; 31: 815-820.
30. Undén J, Christensson B, Bellner J, Alling C, Romner B. Serum S100B levels in patients with cerebral and extracerebral infectious disease. Scand J Infect Dis. 2004; 36: 10-13.